Christian Mueller

Author PubWeight™ 249.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012 10.38
2 Third universal definition of myocardial infarction. J Am Coll Cardiol 2012 8.59
3 Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009 8.05
4 Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006 6.07
5 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013 5.23
6 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2015 5.15
7 Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2009 4.82
8 One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012 4.24
9 Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011 3.72
10 Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. Proc Natl Acad Sci U S A 2009 3.58
11 State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008 3.35
12 High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 2012 2.94
13 Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results. Hum Gene Ther 2011 2.75
14 Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 2013 2.28
15 Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010 2.25
16 Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med 2012 2.14
17 Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007 2.11
18 Pathophysiology of lower extremity edema in acute heart failure revisited. Am J Med 2012 2.03
19 Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A 2011 2.01
20 How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012 2.00
21 Consideration of high-sensitivity troponin values below the 99th percentile at presentation: does it improve diagnostic accuracy? Int J Cardiol 2013 1.99
22 Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol Ther 2011 1.96
23 Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010 1.88
24 The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 2007 1.85
25 Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J 2014 1.81
26 N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction. Am J Med 2011 1.75
27 Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial. Eur Heart J 2012 1.73
28 Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009 1.71
29 Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol 2013 1.69
30 Use of myeloperoxidase for risk stratification in acute heart failure. Clin Chem 2010 1.68
31 The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide. Heart 2011 1.59
32 Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 2011 1.58
33 Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J 2013 1.58
34 QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure. Heart 2007 1.55
35 Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol 2013 1.55
36 Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis. Clin Infect Dis 2004 1.52
37 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev Esp Cardiol (Engl Ed) 2015 1.49
38 Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure. Eur Heart J 2012 1.48
39 Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J 2012 1.48
40 Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail 2011 1.48
41 Quantifying cardiac hemodynamic stress and cardiomyocyte damage in ischemic and nonischemic acute heart failure. Circ Heart Fail 2011 1.44
42 B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain. Am J Med 2011 1.44
43 Baseline platelet count and clinical outcome in acute coronary syndrome. Circ J 2012 1.42
44 Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J 2011 1.42
45 Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 2011 1.40
46 Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011 1.31
47 MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression. Mol Ther 2010 1.30
48 Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol 2013 1.29
49 Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression. J Clin Invest 2013 1.20
50 Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest 2008 1.20
51 Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Am J Gastroenterol 2002 1.17
52 CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008 1.16
53 S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med 2009 1.15
54 Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol 2013 1.13
55 High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012 1.12
56 Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia. J Cereb Blood Flow Metab 2010 1.07
57 Molecular analysis of Phr peptide processing in Bacillus subtilis. J Bacteriol 2003 1.07
58 Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. J Clin Pharmacol 2007 1.07
59 Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction. Heart 2012 1.06
60 Immune responses in cystic fibrosis: are they intrinsically defective? Am J Respir Cell Mol Biol 2012 1.06
61 Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg 2006 1.05
62 Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 2006 1.05
63 Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail 2011 1.05
64 Gene therapy for alpha-1 antitrypsin deficiency. Hum Mol Genet 2011 1.04
65 In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA. Lab Invest 2007 1.03
66 Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure. Crit Care 2011 1.02
67 Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway. Mol Ther 2009 1.01
68 Normal presenting levels of high-sensitivity troponin and myocardial infarction. Heart 2013 1.01
69 Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2011 1.01
70 Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 2006 1.01
71 Heparin strongly induces soluble fms-like tyrosine kinase 1 release in vivo and in vitro--brief report. Arterioscler Thromb Vasc Biol 2011 1.00
72 Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention. Int J Cardiol 2005 0.99
73 New definition of myocardial infarction: impact on long-term mortality. Am J Med 2008 0.98
74 Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET. Eur Heart J 2008 0.97
75 Incidence, risk factors, and outcome of aspiration pneumonitis in ICU overdose patients. Intensive Care Med 2006 0.96
76 Central venous pressure and impaired renal function in patients with acute heart failure. Eur J Heart Fail 2010 0.96
77 Value of arterial blood gas analysis in patients with acute dyspnea: an observational study. Crit Care 2011 0.95
78 Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery. Mol Ther 2008 0.95
79 Use of natriuretic peptide assay in dyspnea. Dtsch Arztebl Int 2008 0.94
80 Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin Chem 2011 0.94
81 Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease. Am J Emerg Med 2012 0.93
82 Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study. J Am Coll Cardiol 2006 0.93
83 Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction. Heart 2013 0.93
84 Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Heart Fail 2012 0.93
85 Copeptin and risk stratification in patients with acute dyspnea. Crit Care 2010 0.91
86 Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men. Am Heart J 2013 0.91
87 Accuracy of chest radiographs in the emergency diagnosis of heart failure. Eur Radiol 2008 0.91
88 Effect and clinical prediction of worsening renal function in acute decompensated heart failure. Am J Cardiol 2011 0.91
89 Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One 2012 0.90
90 Male mice lacking the Theg (testicular haploid expressed gene) protein undergo normal spermatogenesis and are fertile. Biol Reprod 2003 0.90
91 Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. Eur Heart J 2010 0.90
92 High-sensitivity cardiac troponin in acute conditions. Curr Opin Crit Care 2014 0.89
93 Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients. Int J Cardiol 2006 0.89
94 Use of neutrophil count in early diagnosis and risk stratification of AMI. Am J Med 2011 0.89
95 Platelet function testing in acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding? Thromb Haemost 2014 0.87
96 Treatment of instent restenosis following stent-supported renal artery angioplasty. Catheter Cardiovasc Interv 2007 0.87
97 Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain. Am J Med 2012 0.87
98 Haploinsufficiency of the germ cell-specific nuclear RNA binding protein hnRNP G-T prevents functional spermatogenesis in the mouse. Hum Mol Genet 2008 0.86
99 Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia. BMC Infect Dis 2008 0.86
100 Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction. Clin Chem 2011 0.86
101 Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study. Eur J Heart Fail 2011 0.86
102 Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care 2012 0.86
103 How to use C-reactive protein in acute coronary care. Eur Heart J 2013 0.86
104 Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations. Clin Chem 2008 0.86
105 Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study. Crit Care 2009 0.85
106 Growth differentiation factor-15 in the early diagnosis and risk stratification of patients with acute chest pain. Clin Chem 2011 0.85
107 Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med 2005 0.85
108 Gene transfer in skeletal and cardiac muscle using recombinant adeno-associated virus. Curr Protoc Microbiol 2013 0.85
109 Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker? Curr Heart Fail Rep 2012 0.85
110 Use of B-type natriuretic peptide in the management of hypoxaemic respiratory failure. Eur J Heart Fail 2010 0.84
111 Prevalence, extent, and independent predictors of silent myocardial infarction. Am J Med 2013 0.84
112 Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med 2011 0.84
113 Effect of oral β-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study. Crit Care 2010 0.84
114 Galectin-3: a modifiable risk factor in heart failure. Cardiovasc Drugs Ther 2014 0.84
115 B-type natriuretic peptide to predict ductus intervention in infants <28 weeks. Pediatr Res 2008 0.84
116 Use of copeptin in the detection of myocardial ischemia. Clin Chim Acta 2008 0.84
117 Odor and taste interaction on brain responses in humans. Chem Senses 2005 0.83
118 North American B-Type Natriuretic Peptide (BNP) Consensus Working Group. Congest Heart Fail 2008 0.83
119 Apparently nonspecific enzyme elevations after portal vein delivery of recombinant adeno-associated virus serotype 2 vector in hepatitis C virus-infected chimpanzees. Hum Gene Ther 2008 0.83
120 Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases. Mol Med 2012 0.83
121 Risk stratification for 1-year mortality in acute heart failure: classification and regression tree analysis. Swiss Med Wkly 2011 0.83
122 Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2013 0.83
123 [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]. Kardiol Pol 2015 0.82
124 Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease. Respir Med 2009 0.82
125 Early diagnosis of myocardial infarction using absolute and relative changes in cardiac troponin concentrations. Am J Med 2013 0.82
126 Induction of group IVC phospholipase A2 in allergic asthma: transcriptional regulation by TNFα in bronchoepithelial cells. Biochem J 2012 0.81
127 Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation. Am J Cardiol 2009 0.81
128 Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea. Clin Chem 2007 0.81
129 Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department. Int J Cardiol 2007 0.81
130 Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study. Int J Cardiol 2009 0.81
131 B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators. Eur J Heart Fail 2006 0.80
132 Preclinical study design for rAAV. Methods Mol Biol 2011 0.80
133 The use of B-type natriuretic peptides in the intensive care unit. Crit Care Med 2007 0.80
134 Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients. Eur J Heart Fail 2011 0.80
135 Serial changes in high-sensitivity cardiac troponin I in the early diagnosis of acute myocardial infarction. Int J Cardiol 2013 0.80
136 CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes. Cytokine 2008 0.80
137 Natriuretic peptides and their evolving clinical applications. Future Cardiol 2008 0.80
138 Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction. Am J Cardiol 2012 0.80
139 The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiency. Pharmacogenomics 2007 0.80
140 Percutaneous coronary intervention versus coronary artery bypass grafting as primary revascularization in patients with acute coronary syndrome. Am J Cardiol 2008 0.80
141 Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy. Mol Ther 2012 0.80
142 Copeptin response to clinical maximal exercise tests. Clin Chem 2010 0.80
143 Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays. Am Heart J 2013 0.80
144 Emergency department perspectives on B-type natriuretic peptide utility. Congest Heart Fail 2008 0.79
145 Patients with acute coronary syndrome and normal high-sensitivity troponin. Am J Med 2011 0.79
146 Use of B-type natriuretic peptide outside of the emergency department. Int J Cardiol 2008 0.79
147 Limitations of infrared ear temperature measurement in clinical practice. Swiss Med Wkly 2010 0.79
148 The use of B-type natriuretic peptides in coronary artery disease: utile or futile? J Am Coll Cardiol 2007 0.79
149 The novel marker LTBP2 predicts all-cause and pulmonary death in patients with acute dyspnoea. Clin Sci (Lond) 2012 0.79
150 Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. Am J Emerg Med 2010 0.79
151 Biomarkers and peak oxygen uptake in patients with chronic lung disease. Respiration 2010 0.79
152 Cardiovascular biomarkers in the ICU. Curr Opin Crit Care 2009 0.79
153 Osteoporosis case finding in the general practice: phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometry. Osteoporos Int 2005 0.78
154 Novelties in the early management of acute heart failure syndromes. Swiss Med Wkly 2010 0.78
155 Why all the struggle about CK-MB and PCI? Eur Heart J 2012 0.78
156 Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?. Kidney Blood Press Res 2012 0.78
157 Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides. Int J Cardiol 2009 0.78
158 Questions and answers on coronary revascularization: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2015 0.78
159 Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications. Congest Heart Fail 2008 0.78
160 Incremental value of multiplex real-time PCR for the early diagnosis of sepsis in the emergency department. Swiss Med Wkly 2014 0.78
161 Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma. J Immunother 2002 0.78
162 Stability and compatibility of recombinant adeno-associated virus under conditions commonly encountered in human gene therapy trials. Hum Gene Ther Methods 2015 0.78
163 Asthenoteratozoospermia in mice lacking testis expressed gene 18 (Tex18). Mol Hum Reprod 2007 0.78
164 Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin. Int J Cardiol 2012 0.78
165 The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea. Biomarkers 2012 0.78
166 Midregional pro-A-type natriuretic peptide for the evaluation of exercise intolerance. Int J Cardiol 2010 0.77
167 B-type natriuretic peptide in patients undergoing orthopaedic surgery: a prospective cohort study. Eur J Anaesthesiol 2010 0.77
168 Incidence of contrast-induced nephropathy with volume supplementation--insights from a large cohort. Med Princ Pract 2008 0.77
169 Utile or futile: biomarkers in the ICU. Crit Care 2011 0.77
170 Serial changes in highly sensitive cardiac troponin improve the early diagnosis of acute myocardial infarction. Evid Based Med 2012 0.77
171 Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease. Expert Rev Mol Diagn 2015 0.77
172 Response to letters regarding article, "High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease". Circulation 2013 0.77
173 Central venous pressure at emergency room presentation predicts cardiac rehospitalization in patients with decompensated heart failure. Eur J Heart Fail 2010 0.77
174 N-glycosylation augmentation of the cystic fibrosis epithelium improves Pseudomonas aeruginosa clearance. Am J Respir Cell Mol Biol 2010 0.77
175 Clinical application of sensitive cardiac troponin assays: potential and limitations. Biomark Med 2010 0.77
176 Diagnostic and prognostic value of uric acid in patients with acute dyspnea. Am J Med 2009 0.77
177 Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Clin Chem 2007 0.77
178 Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial. BMC Nephrol 2012 0.77
179 Gender differences in acute congestive heart failure. Swiss Med Wkly 2006 0.77
180 [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome) 2016 0.76
181 Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction. Eur J Clin Invest 2015 0.76
182 B-type natriuretic peptide-guided management and outcome in patients with obesity and dyspnea--results from the BASEL study. Am Heart J 2009 0.76
183 Quantitative comparison of the expression of antimicrobial peptides in the oral mucosa and extraoral skin. Br J Oral Maxillofac Surg 2011 0.76
184 Biomarkers and ST-elevation myocardial infarction. Heart 2013 0.76
185 Uric acid for diagnosis and risk stratification in suspected myocardial infarction. Eur J Clin Invest 2012 0.76
186 Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Heart 2012 0.76
187 Gene transfer in the lung using recombinant adeno-associated virus. Curr Protoc Microbiol 2012 0.76
188 Endogenous stress response in Tako-Tsubo cardiomyopathy and acute myocardial infarction. Eur J Clin Invest 2011 0.75
189 Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients. Int J Cardiol 2012 0.75
190 Comment on "High-sensitivity cardiac troponin: hype, help, and reality". Clin Chem 2010 0.75
191 Natriuretic peptide-guided management by the general practitioner: how to interpret the SIGNAL. Eur J Heart Fail 2010 0.75
192 B-type natriuretic peptides and the general practitioner. J Am Coll Cardiol 2007 0.75
193 Differing definitions of contrast-induced nephropathy. Swiss Med Wkly 2005 0.75
194 Acute respiratory failure: back to the roots! Intensive Care Med 2008 0.75
195 Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration. Medicine (Baltimore) 2016 0.75
196 "Universal definition" methodology and conclusions are a concern. J Am Coll Cardiol 2011 0.75
197 Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer. Clin Cancer Res 2004 0.75
198 Troponin testing: end of an era? Clin Biochem 2013 0.75
199 The reply. Am J Med 2013 0.75
200 Effect of allergy and inflammation on eicosanoid gene expression in CFTR deficiency. J Cyst Fibros 2012 0.75
201 Moving forward toward a cure for Parkinson's: neuropathology of the nigrostriatal pathway determines the location of growth factor delivery. Mol Ther 2011 0.75
202 Testing times: we are still some way from getting the best out of sensitive troponin assays--reply. JAMA Intern Med 2013 0.75
203 What is suppression of anti-adeno-associated virus capsid T-cells achieving? Hum Gene Ther 2014 0.75
204 B-type natriuretic peptide in children: step by step... J Am Coll Cardiol 2009 0.75
205 Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo? Int J Cardiol 2012 0.75
206 The use of B-type natriuretic peptides in the detection of myocardial ischemia in settings with rapid access to coronary angiography. Int J Cardiol 2006 0.75
207 Overview of B-type natriuretic peptide as a blood test. Roundtable discussion. Congest Heart Fail 2006 0.75
208 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2020 0.75
209 Use of changes in B-type natriuretic peptides to detect ischemia in selected patients. Int J Cardiol 2008 0.75
210 How safe is the outpatient management of patients with acute chest pain and mildly increased cardiac troponin concentrations? Clin Chem 2012 0.75
211 Disparity of care in the acute care of patients with heart failure. Acad Emerg Med 2011 0.75
212 B-type natriuretic Peptide: application in the community. Congest Heart Fail 2008 0.75
213 GC-R-CF-MS method to determine the 13C abundance of gaseous combustion products in cigarette smoke. Isotopes Environ Health Stud 2007 0.75
214 The use of natriuretic peptides in the intensive care unit. Curr Opin Crit Care 2008 0.75
215 Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial. Emerg Med J 2012 0.75
216 Systolic blood pressure at Emergency Department presentation and 1-year mortality in acute chest pain patients. Eur J Intern Med 2011 0.75
217 Incremental Value of Preoperative Copeptin for Predicting Myocardial Injury. Anesth Analg 2016 0.75
218 Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide. Eur J Appl Physiol 2014 0.75
219 The relationship between chest pain duration and the incidence of acute myocardial infarction among patients with acute chest pain. Crit Pathw Cardiol 2013 0.75
220 Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes. Clin Lab 2017 0.75
221 High-sensitive troponin, B-type natriuretic peptide and coronary angiogram findings in patients with non ST-segment elevation acute coronary syndrome. Int J Cardiol 2011 0.75
222 Effect of the FDA Regulatory Approach on the 0/1-h Algorithm for Rapid Diagnosis of MI. J Am Coll Cardiol 2017 0.75
223 Calgizarrin like gene (Cal) deficient mice undergo normal spermatogenesis. Mol Reprod Dev 2003 0.75
224 Neurohormonal activation and left ventricular ejection fraction in patients with suspected myocardial ischemia. Int J Cardiol 2006 0.75
225 Use of cardiac troponin in the early diagnosis of acute myocardial infarction. Kardiol Pol 2020 0.75
226 MR-guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplantation. Minim Invasive Ther Allied Technol 2007 0.75
227 The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea. Int J Cardiol 2008 0.75
228 An integrated scale-down plant for optimal recombinant enzyme production by Pichia pastoris. Biotechnol J 2011 0.75
229 Tissue damage of non-heart-beating donor lungs after long-term preservation: evaluation of histologic alteration, bronchoalveolar lavage, and energy metabolism. Shock 2002 0.75
230 Cortisol Outperforms Novel Cardiovascular, Inflammatory, and Neurohumoral Biomarkers in the Prediction of Outcome in Acute Pancreatitis. Pancreas 2017 0.75
231 Impact of body temperature on in-hospital and long-term mortality in patients with acute heart failure. Swiss Med Wkly 2008 0.75